Profound Medical (PROF) Enterprise Value (2018 - 2026)

Profound Medical's Enterprise Value history runs 9 years deep, the most recent figure standing at -$50.3 million for Q1 2026.

• On a quarterly basis, Enterprise Value fell 8.32% year-over-year to -$50.3 million in Q1 2026; TTM through Mar 2026 was -$50.3 million, a 8.32% decrease from a year earlier, with the FY2025 full-year figure at -$59.7 million, down 8.76% from the prior year.
• Enterprise Value advanced to -$50.3 million in Q1 2026 per PROF's latest filing, from -$59.7 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$24.8 million in Q3 2025 and bottomed at -$59.7 million in Q4 2025.
• The 5-year median for Enterprise Value is -$46.5 million (2022), against an average of -$43.0 million.
• Across the five-year window, Enterprise Value soared 43.65% in 2023 and slumped 109.48% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$46.5 million in 2022, then surged by 43.65% to -$26.2 million in 2023, then tumbled by 109.48% to -$54.9 million in 2024, then declined by 8.76% to -$59.7 million in 2025, then rose by 15.79% to -$50.3 million in 2026.
• Per Business Quant, the three latest PROF Enterprise Value figures stand at -$50.3 million (Q1 2026), -$59.7 million (Q4 2025), and -$24.8 million (Q3 2025).